BML, Inc.

Historical price data

Founded in 1968, BML has established itself as Japan's preeminent and mission-critical provider of clinical laboratory testing services, supporting hospitals, clinics, and pharmaceutical R&D. Its achievements are built on a vast, automated, and certified laboratory network that ensures rapid, reliable diagnostics nationwide. The company's strategy leverages this dominant service foundation to selectively expand into adjacent high-value areas, including biotech research and therapeutic development, aiming to capture more of the precision medicine value chain.

A nationwide, integrated service platform comprising high-throughput automated laboratories, advanced diagnostic instrumentation (NGS, MS), and a proprietary IT/LIMS ecosystem for sample management and data integration.

In its core testing business, BML operates in a domestic duopoly primarily with SRL, Inc., competing on scale and service. In CRO services, it faces global and regional players. Its therapeutic R&D enters a highly competitive arena against established biopharma firms.